Janne Damm Olling

Janne Damm Olling has extensive experience in the biopharmaceutical sector, currently serving as Director of Non-clinical Safety and Regulatory Strategy at Ascendis Pharma since November 2017. Prior to this role, Janne worked at Novo Nordisk from November 2009 to October 2017, where responsibilities included serving as SEND Project Manager and Senior Scientist, focusing on non-clinical safety assessments and immunotoxicology. Janne began a career in research with a postdoctoral position at Psykiatrisk Center Gentofte and a PhD at the University of Copenhagen, complemented by early roles at Lundbeck and Sct. Hans Hospital. Janne holds a Cand. scient. degree in Biology from the University of Copenhagen.